In Brief: ChiRex acetaminophen business
This article was originally published in The Tan Sheet
Executive Summary
ChiRex acetaminophen business: Being sold by the contract manufacturing organization to Rhone-Poulenc Chimie SA, Wellesley, Mass.-based ChiRex announces April 9. Under the agreement, for which ChiRex expects to receive net proceeds of $6.3 mil., the company will continue to manufacture acetaminophen (APAP) for RPC "for a period to effect a seamless transfer of customers," ChiRex reports. The sale reflects ChiRex' intention to divest low-margin, low-growth, non-core products and focus on being a CMO for the pharmaceutical industry, the company says. The APAP production facility is in Dudley, Northumberland, England...